Leadership & Pay · · GlobeNewswire
Jade Biosciences Appoints Mark Eisner to Board of Directors
JBIOJade Biosciences, Inc.
Jade Biosciences announced the appointment of Mark Eisner, M.D., M.P.H., to its Board of Directors, effective June 25, 2026. Dr. Eisner joins with more than 25 years of leadership in clinical development and immunology, most recently serving as Executive Vice President and Chief Medical Officer at Vir Biotechnology. He previously held CMO roles at Sonoma Biotherapeutics and FibroGen, and spent nearly 11 years at Genentech/Roche. Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases.